๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients

โœ Scribed by Michael Tachezy; Katharina Effenberger; Hilke Zander; Sarah Minner; Florian Gebauer; Yogesh K. Vashist; Guido Sauter; Klaus Pantel; Jakob R. Izbicki; Maximilian Bockhorn


Book ID
112101564
Publisher
John Wiley and Sons
Year
2011
Tongue
French
Weight
449 KB
Volume
131
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Low serum albumin levels and liver metas
โœ Dragan Trivanovic; Marija Petkovic; Davor Stimac ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 38 KB

W e read with interest the results from the study of serum albu- min and liver metastasis in patients with carcinomas of unknown primary site by Seve et al. 1 We can present some results from our unpublished study in patients with cancer of unknown primary site in which we explored a set of possible

High expression of leptin receptor mRNA
โœ Yasuo Miyoshi; Tohru Funahashi; Sachiyo Tanaka; Tetsuya Taguchi; Yasuhiro Tamaki ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 330 KB

The association of mRNA expression levels of leptin receptors (long isoform: Lep-R(L) and short isoform: Lep-R(S)) in breast cancer tissue with patient prognosis was studied with special reference to the serum leptin level or the leptin mRNA level in tumor tissue. Lep-R(L), Lep-R(S) and leptin mRNA